Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy

Journal of Medical Virology

Volumn 83, Issue 10, 2011, Pages 1818-1825

  Ruppert, Volker ^a   Meyer, Thomas ^b   Balbach, Anna ^a   Richter, Anette ^a   Müller, Hans Helge ^c   Maisch, Bernhard ^a   Pankuweit, Sabine ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dilated cardiomyopathy; Myocarditis; Parvovirus

Indexed keywords

IMMUNOGLOBULIN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ERYTHEMA INFECTIOSUM; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; VIRUS DETECTION; VIRUS GENOME;

ADULT; AGED; BASE SEQUENCE; CARDIOMYOPATHY, DILATED; DNA, VIRAL; FEMALE; GENOTYPE; HEART; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; VENTRICULAR FUNCTION, LEFT; VIRAL LOAD;

PARVOVIRUS;

EID: 80051585274     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22187     Document Type: Article

References (24)

1. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. 1987. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 316: 183-186.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Barlett CL, Cohen BJ, Mortimer PP, Pereira MS. 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1: 1378.
3. Bock CT, Klingel K, Kandolf R. 2010. Human parvovirus B19-associated myocarditis. N Engl J Med 362: 1248-1249.
4. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. 2005. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193: 363-365.
5. Bültmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R. 2003. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease. Hum Pathol 34: 92-95.
6. Corcioli F, Zakrzewska K, Rinieri A, Fanci R, Innocenti M, Civinini R, De Giorgi V, Di Lollo S, Azzi A. 2008. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J Med Virol 80: 2005-2011.
7. Dijkmans BA, van Elsacker-Niele AM, Salimans MM, van Albada-Kuipers GA, de Vries E, Weiland HT. 1988. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 31: 279-281.
8. Escher F, Modrow S, Sabi T, Kühl U, Lassner D, Schultheiss HP, Noutsias M. 2008. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Med Sci Monit 14: CR589-CR597.
9. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 107: 857-863.
10. Kühl U, Lassner D, Pauschinger M, Gross UM, Seeberg B, Noutsias M, Poller W, Schultheiss HP. 2008. Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol 80: 1243-1251.
11. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970.
12. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwanebeck U, Modrow S. 2009. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49: 1660-1666.
13. Lindner J, Noutsias M, Lassner D, Wenzel J, Schultheiss HP, Kuehl U, Modrow S. 2009. Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J Clin Virol 44: 27-32.
14. Lotze U, Egerer R, Glück B, Zell R, Sigusch H, Erhardt C, Heim A, Kandolf R, Bock T, Wutzler P, Figulla HR. 2010. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. J Med Virol 82: 1449-1457.
15. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hübinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Söderlund-Venermo M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103: 7450-7453.
16. Norja P, Eis-Hübinger AM, Söderlund-Venermo M, Hedman K, Simmonds P. 2008. Rapid sequence change and geographical spread of human parvovirus B19: Comparison of B19 virus evolution in acute and persistent infections. J Virol 82: 6427-6433.
17. Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B. 2003. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34: 497-503.
18. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, Murtaza L. 1981. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1: 664-665.
19. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. 1996. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841-842.
20. Schenk T, Enders M, Pollak S, Hahn R, Huzly D. 2009. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47: 106-110.
21. Schmidt-Lucke C, Spillmann F, Bock T, Kühl U, Van Linthout S, Schultheiss HP, Tschöpe C. 2010. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection. J Infect Dis 201: 936-945.
22. Schowengerdt KO, Ni J, Denfield SW, Gajarski RJ, Bowles NE, Rosenthal G, Kearney DL, Price JK, Rogers BB, Schauer GM, Chinnock RE, Towbin JA. 1997. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Diagnosis using the polymerase chain reaction. Circulation 96: 3549-3554.
23. Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kühl U, Kandolf R, Schultheiss HP. 2005. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886.
24. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, Caul O, Dieppe PA. 1989. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149: 1153-1156.